Article
Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study.
Drug and alcohol dependence - 15 Dec 2013
Ashare Rebecca L, Wileyto E Paul, Ruparel Kosha, Goelz Patricia M, Hopson Ryan D, Valdez Jeffrey N, Gur Ruben C, Loughead James, Lerman Caryn
Abstract excerpt
BACKGROUND: Dopamine levels in the prefrontal cortex (PFC) are thought to play an important role in cognitive function and nicotine dependence. The catechol-O-methyltransferase (COMT) inhibitor tolcapone, an FDA-approved treatment for Parkinson's disease, increases prefrontal dopamine levels, with cognitive benefits that may vary by COMT genotype. We tested whether tolcapone alters working memory-related brain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
